Blog

  • All
  • Blog
  • News

Cannabis Oils: A Beginner’s Guide

Cannabis oils – what are they? Simply put, cannabis oils are extracts from cannabis plants that contain cannabinoids. Now you may have heard of different names for cannabis oils, including THC oil and CBD oil. While both fall under the umbrella term ‘cannabis oil’, there are striking differences. CBD vs. THC Cannabidiol, or CBD is

Greater Healthcare Transparency for Canadians: Health Canada to start providing public access to protected drug and medical device data

Millions of Canadians rely on drugs and medical devices to maintain their quality of life and overcome medical ailments. However, access to the clinical evidence that is used to approve these therapeutic products is restricted to Health Canada. Consequently, Canadians are shielded from safety issues, adverse events, and results from pre-market testing, and some feel

International Women’s Day Q&A with Navneet Sekhon, President and Founder of AxSource Consulting Inc.

March 8th, 2019 marks International Women’s Day, an annual celebration of the social, economic, and political achievements of women globally. This year’s theme is ‘Balance for Better’, encouraging a gender balanced workforce. To celebrate this day, we asked Navneet Sekhon, the President and Founder of AxSource Consulting Inc. about her role, accomplishments, and opinions about

Rare Disease Day: What is a Rare Disease and What are Orphan Drugs?

What is a Rare Disease? A rare disease is a life-threatening, seriously debilitating or chronic condition affecting a fairly small number of patients. A disease may be considered rare in one part of the world, or in a particular group of people, but still be common in another. For instance, in the United States the

Navneet Sekhon’s Perspective on Good Manufacturing Practices for Dynamics 365 & AX

It is with excitement we announce that AxSource® Consulting President, Navneet Sekhon, will be speaking at the AXUG Summit EMEA on April 24th 2018 in Dublin. For four consecutive years, Navneet has been in attendance and finally, her time has as she shares her wealth of knowledge in her first seminar at the AXUG Summit

Data Integrity Violation In Pharma

Pharmaceutical companies have a duty to the FDA and other authorities to keep their data accurate, unaltered, and properly stored in their database. Not only should the data be stored, but it should also be maintained through error checking and validation routines. Failure to do so will result in a violation of the FDA’s manufacturing

Volatility of Pharma and Biopharma in 2017

The beginning of a new year usually implies a fresh, optimistic start, but it would appear that things are still not looking good for pharmaceutical companies in 2017. The life sciences sector has seen some rough times in 2016 already—Donald Trump’s criticisms of the pharmaceutical industry alone raised more than one issue and certainly caused

Personalized Medicine an Effort to Revolutionize Health Care

“It is far more important to know what person the disease has than what disease the person has” Patients, clinicians, drug manufacturers and IT specialists- everyone has a personalized stake on ‘personalized’ medicine, and it is quite evident these days. The way we foresee the evolution of personalized medicine differs with respect to the perspective

Does Computer System Validation Apply To You?

Computer System Validation has been a regulatory (e.g. FDA, Health Canada) requirement for more than two decades. Nevertheless, companies have problems with its understanding, scope, implementation and maintenance. This is proven through many FDA warning letters related to device software and computer system validation. IT professionals know the principles but have problems with its implementation,

Why should life sciences companies choose Microsoft Dynamics?

The pharmaceutical and life science industry is among one of the most heavily regulated and scrutinized in the world. These businesses are constantly adapting to numerous regulatory requirements set by governing bodies around the globe like Health Canada and the FDA. Business practices for these life science companies must be compliant with regulatory and quality